Regeneron Pharmaceuticals, Inc.
METHODS FOR MITIGATING DRUG TARGET INTERFERENCE IN AN ANTI-DRUG ANTIBODY (ADA) IMMUNOASSAY
Last updated:
Abstract:
The present disclosure provides methods for mitigating drug target interference in an anti-drug antibody (ADA) immunoassay, wherein the ADA immunoassay comprises one or more target blocking reagents under mild basic pH assay conditions.
Status:
Application
Type:
Utility
Filling date:
9 Jul 2019
Issue date:
16 Jan 2020